-
Lucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Canaccord Genuity Group
Source: Buzz FX / 14 Nov 2024 11:31:18 America/Chicago
Lucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Canaccord Genuity Group Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Lucid Diagnostics ( NASDAQ:LUCD - Get Free Report ) 's stock had its "buy" rating reaffi
Read more...